OverviewSuggest Edit

Illumina is a company that develops, manufactures, and markets sequencing- and array-based integrated systems for genetic and genomic analysis. The company provides a line of products and services for DNA sequencing, genotyping, and gene expression applications. Its platforms support the scale of experimentation necessary for population-scale studies, genome-wide discovery, target selection, and validation studies. Illumina also offers instruments and consumables, which include reagents, flow cells, and microarrays. The company serves genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government laboratories, hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
TypePublic
Founded1998
HQSan Diego, CA, US
Websiteillumina.com
Employee Ratings4.1
Overall CultureA+

Latest Updates

Employees (est.) (Jan 2021)7,800(+2%)
Job Openings1,003
Revenue (FY, 2020)$3.2 B(-8%)
Share Price (Sept 2021)$448.9
Cybersecurity ratingCMore

Key People/Management at Illumina

Francis deSouza

Francis deSouza

Chief Executive Officer
Phil Febbo

Phil Febbo

Chief Medical Officer
Aimee Hoyt

Aimee Hoyt

Chief People Officer
Bob Ragusa

Bob Ragusa

Chief Operations Officer
Kathryne Reeves

Kathryne Reeves

Chief Marketing Officer
Sam Samad

Sam Samad

Chief Financial Officer
Show more

Illumina Office Locations

Illumina has offices in San Diego, Baltimore, Foster City, Hayward and in 13 other locations
San Diego, CA, US (HQ)
5200 Illumina Way
Baltimore, MD, US
801 W Baltimore St #500
Foster City, CA, US
200 Lincoln Centre Dr
Hayward, CA, US
25861 Industrial Blvd
Madison, WI, US
524 Genomic Dr
San Diego, CA, US
4795 Executive Dr
Show all (19)

Illumina Financials and Metrics

Illumina Revenue

Embed Graph
View revenue for all periods
Illumina's revenue was reported to be $3.24 b in FY, 2020
USD

Revenue (Q2, 2021)

1.1b

Gross profit (Q2, 2021)

802.0m

Gross profit margin (Q2, 2021), %

71.2%

Net income (Q2, 2021)

185.0m

EBIT (Q2, 2021)

187.0m

Market capitalization (14-Sept-2021)

65.5b

Closing stock price (14-Sept-2021)

448.9

Cash (4-Jul-2021)

4.2b

EV

63.7b
Illumina's current market capitalization is $65.5 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

3.3b3.5b3.2b

Revenue growth, %

21%6%

Cost of goods sold

1.0b1.1b1.0b

Gross profit

2.3b2.5b2.2b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Revenue

846.0m838.0m907.0m859.0m633.0m794.0m1.1b1.1b

Cost of goods sold

262.0m265.0m259.0m240.0m205.0m268.0m329.0m324.0m

Gross profit

584.0m573.0m648.0m619.0m428.0m526.0m764.0m802.0m

Gross profit Margin, %

69%68%71%72%68%66%70%71%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

1.1b2.0b1.8b

Accounts Receivable

514.0m573.0m487.0m

Prepaid Expenses

78.0m105.0m152.0m

Inventories

386.0m359.0m372.0m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021

Cash

2.3b1.9b1.8b2.0b1.8b1.8b4.4b4.2b

Accounts Receivable

457.0m470.0m541.0m472.0m385.0m464.0m517.0m540.0m

Prepaid Expenses

61.0m93.0m98.0m136.0m106.0m126.0m131.0m104.0m

Inventories

412.0m420.0m417.0m384.0m435.0m415.0m364.0m380.0m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

678.0m782.0m990.0m656.0m

Depreciation and Amortization

156.0m179.0m188.0m187.0m

Inventories

(33.0m)(53.0m)25.0m(12.0m)

Accounts Payable

10.0m45.0m(35.0m)40.0m
Show all financial metrics

Illumina Operating Metrics

Illumina's Backlog was reported to be $816m in FY, 2021.
FY, 2017FY, 2018FY, 2019FY, 2021

Backlog

$935 m$909 m$980 m$816 m

Patent Applications (US)

473529617650

Patents (US)

719709799901
Show all operating metrics

Illumina Acquisitions / Subsidiaries

Company NameDateDeal Size
GrailSeptember 21, 2020$8 b
EnancioJuly 14, 2020
BlueBeeJune 17, 2020
Edico GenomeMay 15, 2018$100 m
Conexio GenomicsJanuary 27, 2016
GenoLogicsAugust 04, 2015
NextBioOctober 28, 2013
Liquid LogicJuly 23, 2013$96 m
MoleculoJanuary 08, 2013
Verinata HealthJanuary 07, 2013$350 m
Show more

Illumina Revenue Breakdown

Embed Graph

Illumina revenue breakdown by business segment: 71.1% from Consumables, 13.3% from Instruments and 15.6% from Service and other revenue

Illumina revenue breakdown by geographic segment: 27.4% from Europe, Middle East, and Africa, 10.6% from Greater China, 53.8% from Americas and 8.2% from Asia-Pacific

Human Capital Metrics

Embed Graph
Show all human capital metrics

Illumina Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

SecurityScorecard logo

Illumina Online and Social Media Presence

Embed Graph

Illumina Company Culture

  • Overall Culture

    A+

    81/100

  • CEO Rating

    A+

    84/100

  • Compensation

    A

    81/100

  • Diversity

    A+

    82/100

Learn more on Comparably

Illumina News and Updates

Worldwide Next-Generation Sequencing Data Analysis Industry to 2028 - Featuring QIAGEN, Illumina and Thermo Fisher Scientific Among Others

Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "Global Next-Generation Sequencing Data Analysis Market Size, Share & Trends Analysis Report by Product, by Workflow, by Mode, by Read Length, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com…

Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050

SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the...

Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050

Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the United Nations campaign Race to Zero.

Feds sue luxury watch dealer for Illumina insider trading - The San Diego Union - Tribune

Feds sue luxury watch dealer for Illumina insider trading - The San Diego Union - Tribune

Illumina Partners With Merck To Develop Tests For Use In Identifying Specific Cancer Mutations

Illumina Inc. (ILMN) and Merck & Co Inc. (MRK) have partnered to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency or HRD, Illumina said in a statement.
Show more

Illumina Frequently Asked Questions

  • When was Illumina founded?

    Illumina was founded in 1998.

  • Who are Illumina key executives?

    Illumina's key executives are Francis deSouza, Phil Febbo and Aimee Hoyt.

  • How many employees does Illumina have?

    Illumina has 7,800 employees.

  • What is Illumina revenue?

    Latest Illumina annual revenue is $3.2 b.

  • What is Illumina revenue per employee?

    Latest Illumina revenue per employee is $415.3 k.

  • Who are Illumina competitors?

    Competitors of Illumina include Qiagen, Luminex and BGI Genomics.

  • Where is Illumina headquarters?

    Illumina headquarters is located at 5200 Illumina Way, San Diego.

  • Where are Illumina offices?

    Illumina has offices in San Diego, Baltimore, Foster City, Hayward and in 13 other locations.

  • How many offices does Illumina have?

    Illumina has 19 offices.